PT89935A - Processo para a preparacao de novos compostos cefem - Google Patents

Processo para a preparacao de novos compostos cefem

Info

Publication number
PT89935A
PT89935A PT89935A PT8993589A PT89935A PT 89935 A PT89935 A PT 89935A PT 89935 A PT89935 A PT 89935A PT 8993589 A PT8993589 A PT 8993589A PT 89935 A PT89935 A PT 89935A
Authority
PT
Portugal
Prior art keywords
alkyl
preparation
pharmaceutically acceptable
amino
hydrogen
Prior art date
Application number
PT89935A
Other languages
English (en)
Other versions
PT89935B (pt
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of PT89935A publication Critical patent/PT89935A/pt
Publication of PT89935B publication Critical patent/PT89935B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
PT89935A 1988-03-09 1989-03-08 Processo para a preparacao de novos compostos cefem PT89935B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888805642A GB8805642D0 (en) 1988-03-09 1988-03-09 New cephem compounds & processes for preparation thereof

Publications (2)

Publication Number Publication Date
PT89935A true PT89935A (pt) 1989-11-10
PT89935B PT89935B (pt) 1994-05-31

Family

ID=10633141

Family Applications (1)

Application Number Title Priority Date Filing Date
PT89935A PT89935B (pt) 1988-03-09 1989-03-08 Processo para a preparacao de novos compostos cefem

Country Status (19)

Country Link
EP (1) EP0332156B1 (pt)
JP (1) JP2827260B2 (pt)
KR (1) KR890014561A (pt)
CN (1) CN1036959A (pt)
AT (1) ATE146476T1 (pt)
AU (1) AU617154B2 (pt)
DE (1) DE68927554D1 (pt)
DK (1) DK113289A (pt)
FI (1) FI891087A (pt)
GB (1) GB8805642D0 (pt)
HU (1) HUT49887A (pt)
IL (1) IL89454A0 (pt)
NO (1) NO890996L (pt)
NZ (1) NZ228254A (pt)
OA (1) OA09239A (pt)
PH (1) PH25911A (pt)
PT (1) PT89935B (pt)
RU (1) RU1804462C (pt)
ZA (1) ZA891622B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5215982A (en) * 1989-11-10 1993-06-01 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
EP0517041A1 (en) * 1991-06-07 1992-12-09 Fujisawa Pharmaceutical Co., Ltd. New Cephem Compounds
JPH09110877A (ja) * 1995-10-17 1997-04-28 Katayama Seiyakushiyo:Kk セフェム化合物、その製造法及びそれを含有する抗菌剤
AUPN955596A0 (en) * 1996-04-30 1996-05-23 Fujisawa Pharmaceutical Co., Ltd. New compound
WO1998045290A1 (fr) * 1997-04-04 1998-10-15 Tokuyama Corporation Derives de 2-aminothiazoleacetamide
CN1852715A (zh) * 2003-09-18 2006-10-25 安斯泰来制药有限公司 头孢类化合物
WO2011061679A1 (en) 2009-11-23 2011-05-26 Pfizer Inc. Imidazo-pyrazoles as gpr119 inhibitors
US9751894B2 (en) 2015-12-10 2017-09-05 Naeja-Rgm Pharmaceuticals Inc. Cephem compounds, their production and use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4331666A (en) * 1979-05-11 1982-05-25 Farmitalia Carlo Erba S.P.A. 3-[(8-Carboxy-6-tetrazolo[1,5-b]pyridazinyl)-thiomethyl]-7-[2-(2-amino-4-thiazolyl)-2-methoxyimino-acetamido]-3-cephem-4-carboxylic acid
EP0062321B1 (en) * 1981-04-03 1989-03-01 Fujisawa Pharmaceutical Co., Ltd. New cephem compounds, processes for their preparation, pharmaceutical compositions containing them and their starting compounds
AU8808882A (en) * 1982-01-19 1983-03-17 Eli Lilly And Company Thieno and furopyridinium-substituted cephalosporin derivatives
DE3336757A1 (de) * 1983-10-08 1985-04-25 Hoechst Ag, 6230 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
PH22107A (en) * 1984-06-07 1988-06-01 Takeda Chemical Industries Ltd 3-pyrazolo(1,5-a)pyrdinium cephem compounds
US4929612A (en) * 1987-04-17 1990-05-29 Eisai Co., Ltd. Thiadiazolylacetamide cephem derivatives

Also Published As

Publication number Publication date
EP0332156A3 (en) 1991-10-16
AU3101789A (en) 1989-09-14
NO890996D0 (no) 1989-03-08
PH25911A (en) 1991-12-19
FI891087A (fi) 1989-09-10
ZA891622B (en) 1989-11-29
DE68927554D1 (de) 1997-01-30
IL89454A0 (en) 1989-09-10
RU1804462C (en) 1993-03-23
HUT49887A (en) 1989-11-28
GB8805642D0 (en) 1988-04-07
ATE146476T1 (de) 1997-01-15
DK113289A (da) 1989-09-10
AU617154B2 (en) 1991-11-21
JP2827260B2 (ja) 1998-11-25
PT89935B (pt) 1994-05-31
JPH0215091A (ja) 1990-01-18
NZ228254A (en) 1990-08-28
OA09239A (fr) 1992-06-30
NO890996L (no) 1989-09-11
EP0332156A2 (en) 1989-09-13
KR890014561A (ko) 1989-10-24
DK113289D0 (da) 1989-03-08
FI891087A0 (fi) 1989-03-08
CN1036959A (zh) 1989-11-08
EP0332156B1 (en) 1996-12-18

Similar Documents

Publication Publication Date Title
PT92935A (pt) Processo para a preparacao de um composto de pirazolo-piridina e de composicoes farmaceuticas que o contem
PT94925A (pt) Processo para a preparacao de derivados de tiazol e de composicoes farmaceuticas que os contem
ATE109149T1 (de) 3-pyrrolidinylthio-1-azabicyclo(3.2.0>-hept-2-e - 2-carbonsäureverbindungen.
PT98358A (pt) Processo para a preparacao de novos compostos pirazolopiridinicos
PT89769A (pt) Processo para a preparacao de derivados do acido 3-alcenil-1-azabiciclo-{3,2,0}hept-2-eno-2-carboxilico
DE68916071D1 (de) 3-Pyrrolidinylthio-1-azabicyclo (3.2.0)hept-2-en-2-carbonsäure-Verbindungen.
IL110151A0 (en) Amide and urea derivatives and pharmaceutical compositions containing the same
ES513420A0 (es) "procedimiento para preparar derivados de 2-oxoazetidina".
PT90725A (pt) Processo para a preparacao de novos compostos cefem
PT89935A (pt) Processo para a preparacao de novos compostos cefem
PT92147A (pt) Processo para a preparacao de derivados de pirrolidina

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19931123

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19950531